Cuorips Inc. (4894.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 11Sep 16Sep 24Sep 29Oct 2Oct 7Oct 13Oct 16

Key dataOct 16, 2026

OpenJPY 6,150.00

From 52W high−48.10%

Volume83700.00

Market capJPY 50.77B

P/E (TTM)—

P/S (TTM)394.8x

Div yield—

Key dataOct 16, 2026

Open

JPY 6,150.00

From 52W high

−48.10%

Volume

83700.00

Market cap

JPY 50.77B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−42.3x

P/E (TTM)

—

RSI (14)

55.7

MomentumView details →

1D Return

−4.05%

YTD Return

+3.98%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−42.3x

EV/Sales

369.1x

P/S (TTM)

394.8x

P/B (TTM)

11.4x

ProfitabilityView details →

Gross Margin

47.26%

Net Margin

−214.89%

EBITDA Margin

−144.19%

ROE (TTM)

−15.21%

ROA (TTM)

−14.67%

Asset Turnover

0.07x

GrowthView details →

Revenue YoY

+947.06%

EPS YoY

+0.41%

FCF YoY

—

Revenue CAGR 3Y

+660.87%

EPS CAGR 3Y

+6.22%

EBITDA YoY

—

MomentumView details →

1D Return

−4.05%

YTD Return

+3.98%

1Y Return

−3.24%

RSI (14)

55.7

vs 50D SMA

+11.38%

vs 200D SMA

+2.34%

Capital & dividendView details →

Debt/Equity

—

Current Ratio

37.06x

Quick Ratio

36.81x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

356.00M

Net Income (TTM)

−765.00M

Op. CF (TTM)

—

Next earningsNov 13, 2026 →

Latest newsMore news →

Cuorips announced that a heart muscle sheet made from iPS cells, ReHeart, was transplanted into a woman in her 50s with ischemic cardiomyopathy at a hospital in Osaka, marking the world's first clinical use of an iPS cell product.17d ago

AstraZeneca's Japan subsidiary invited three Japanese drug-discovery and medical-device startups, including Cuorips, to its global headquarters in Cambridge, UK, for discussions on overseas expansion as part of an Osaka Prefecture-backed startup support program.31d ago

Similar companies

TAUNS Laboratories,Inc.197A.T Fuji Pharma Co.,Ltd.4554.T ASKA Pharmaceutical Holdings Co.,Ltd.4886.T Heartseed Inc.219A.T Daito Pharmaceutical Co.,Ltd.4577.T KYORIN Pharmaceutical Co.,Ltd.4569.T Find similar companies →

Latest newsMore news →

Cuorips announced that a heart muscle sheet made from iPS cells, ReHeart, was transplanted into a woman in her 50s with ischemic cardiomyopathy at a hospital in Osaka, marking the world's first clinical use of an iPS cell product.17d ago AstraZeneca's Japan subsidiary invited three Japanese drug-discovery and medical-device startups, including Cuorips, to its global headquarters in Cambridge, UK, for discussions on overseas expansion as part of an Osaka Prefecture-backed startup support program.31d ago